MedTrace Logo

Multicenter Myocardial Viability Trial

NCT00661232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 235

Last updated 2020-12-02

No results posted yet for this study

Summary

The purpose of this study is to test the hypothesis of whether contrast enhanced Magnetic Resonance Imaging can be used to predict improvement of the wall motion in regions of the heart with abnormal movement following bypass surgery or percutaneous angioplasty in various institutions across three continents.

Conditions

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • CHI St. Luke's Health, Texas

    lead OTHER

Principal Investigators

  • Scott D Flamm, M.D. · CHI St. Luke's Health, Texas

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-11
Primary Completion
2011-01-14
Completion
2011-05-15

Countries

  • United States
  • Belgium
  • Denmark
  • Greece
  • Thailand
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00661232 on ClinicalTrials.gov